This partly explains the existence of PLAUR amplification in CTCs from patients with HER2-positive BC [33] and is consistent with previous reports that showed marked preference for amplification of both HER2 and PLAUR genes to occur in the same CTC in HER2-amplified tumors [144, 145]. This evidence concerns the gene ERBB2 and breast cancer.